NYSE:ABBVBiotechs
AbbVie’s MLB Cancer Push And Psychedelic Bet Versus Lofty Valuation
AbbVie (NYSE:ABBV) has entered a multi year partnership with Major League Baseball to expand its cancer awareness campaign across the league.
The company has also acquired bretisilocin, a psychedelic drug candidate in Phase 2 development for major depressive disorder.
For investors following NYSE:ABBV, these updates touch two different parts of the story: brand reach and drug pipeline. The MLB partnership puts AbbVie’s cancer awareness efforts in front of a national audience, which can...